NCT07156227 2026-03-18
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
Phase 1 Not yet recruiting
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Canadian Cancer Trials Group
Chinese University of Hong Kong
NRG Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Peking University People's Hospital
Swansea Bay University Health Board